Diarrhoea News and Research

RSS

Review outlines effective approaches to reduce recurrent hepatic encephalopathy

Hepatic encephalopathy (HE) is a neurologic complication of advanced liver disease, causing impaired functioning, reduced quality of life (QOL), and increased hospitalisation and mortality.

31 Jul 2026

AI reveals effective combination therapy for advanced rectal cancer

Artificial intelligence developed by researchers at UCL has revealed a promising combination of cancer treatments that could help patients with locally advanced rectal cancer live longer.

27 Jul 2026

Industrial chicken farming drives evolution of foodborne bacteria strains

A new study by the Ineos Oxford Institute for antimicrobial research, University of Oxford, reveals that industrial poultry farming has led to more than 100-fold increase in the movement of Campylobacter, allowing strains that once circulated in wild birds to mix extensively in commercial poultry populations.

27 Jul 2026

New study tracks rapid spread of drug-resistant Shigella across England

A nationwide genomic epidemiology study involving a researcher from Kingston University has revealed that sexually transmitted Shigella sonnei is spreading faster, over greater geographic distances and with higher transmission intensity than non-sexually transmitted strains in England.

27 Jul 2026

Genetic research reveals surprising metabolic pathway for irritable bowel syndrome

Irritable bowel syndrome (IBS) is a common condition that affects more than 10% of the general population, causing recurrent abdominal pain, bloating, constipation and diarrhea.

9 Jul 2026

Targeted therapy shows promise against KRAS-driven metastatic pancreatic cancer

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown promising early results when combined with standard first-line chemotherapy, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026.

3 Jul 2026

Study identifies genetic marker associated with severe IBD

In the largest genetic study of inflammatory bowel disease (IBD) traits to date, researchers have identified a genetic marker that is associated with more severe ulcerative colitis and Crohn's disease – the major forms of IBD.

15 Jun 2026

Researchers urge one health approach to control raccoon-borne water contamination

The emerging infectious bacterium Escherichia albertii has caused outbreaks of severe food poisoning and hospitalized people through contaminated water and foods, such as salad ingredients. Now, a new study from Osaka Metropolitan University (OMU) has gathered evidence from river, animal and genetic samples that suggest a pathway by which invasive raccoons (Procyon lotor) transmit infections to humans.

12 Jun 2026

Study challenges structural explanation for gut symptoms in hEDS patients

A study, led by experts at the University of Nottingham, has found that persistent and distressing upper gut symptoms experienced by people with hypermobile Ehlers-Danlos syndrome (hEDS), are not due to structural problems with the gullet (esophagus), as previously assumed.

13 May 2026

Machine learning speeds up AMP discovery for treating ulcerative colitis

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by recurrent intestinal inflammation, abdominal pain and diarrhea.

23 Mar 2026

New report provides the most detailed picture of preventable child deaths worldwide

An estimated 4.9 million children died before their fifth birthday in 2024, including 2.3 million newborns, according to new estimates released today.

18 Mar 2026

Children develop stronger immunity after repeated infections in nursery

Young children who attend nursery get sick more often than those who don't, but they will go on to have fewer illnesses during early school years, finds a new review of evidence by a group of parent-scientists involving University College London (UCL) researchers.

18 Mar 2026

Expanded vaccine supply allows resumption of cholera prevention campaigns

Global cholera vaccine supply has now increased to a level sufficient to allow the resumption of life-saving preventive campaigns for the first time in over three years, Gavi, the Vaccine Alliance, UNICEF, and the World Health Organization (WHO) announced today.

5 Feb 2026